- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Personal Genome Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Personal Genome Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Neurological Disorders accounting for % of the Personal Genome Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Targeted Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Personal Genome Testing include 23andMe, Inc., Navigenics, deCODEme, Color Genomics, Inc., and Personal Genome Diagnostics, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Personal Genome Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted Testing
Non-Targeted Testing
Multi-Targeted Testing
Market segment by Application, can be divided into
Neurological Disorders
Oncology
Metabolic Disorders
Autoimmune Disorders
Others
Market segment by players, this report covers
23andMe, Inc.
Navigenics
deCODEme
Color Genomics, Inc.
Personal Genome Diagnostics, Inc.
Counsyl, Inc.
Quest Diagnostics
Gene By Gene, Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Personal Genome Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Personal Genome Testing, with revenue, gross margin and global market share of Personal Genome Testing from 2019 to 2022.
Chapter 3, the Personal Genome Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Personal Genome Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Personal Genome Testing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Personal Genome Testing
1.2 Classification of Personal Genome Testing by Type
1.2.1 Overview: Global Personal Genome Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Personal Genome Testing Revenue Market Share by Type in 2021
1.2.3 Targeted Testing
1.2.4 Non-Targeted Testing
1.2.5 Multi-Targeted Testing
1.3 Global Personal Genome Testing Market by Application
1.3.1 Overview: Global Personal Genome Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Neurological Disorders
1.3.3 Oncology
1.3.4 Metabolic Disorders
1.3.5 Autoimmune Disorders
1.3.6 Others
1.4 Global Personal Genome Testing Market Size & Forecast
1.5 Global Personal Genome Testing Market Size and Forecast by Region
1.5.1 Global Personal Genome Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Personal Genome Testing Market Size by Region, (2017-2022)
1.5.3 North America Personal Genome Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Personal Genome Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Personal Genome Testing Market Size and Prospect (2017-2028)
1.5.6 South America Personal Genome Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Personal Genome Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Personal Genome Testing Market Drivers
1.6.2 Personal Genome Testing Market Restraints
1.6.3 Personal Genome Testing Trends Analysis
2 Company Profiles
2.1 23andMe, Inc.
2.1.1 23andMe, Inc. Details
2.1.2 23andMe, Inc. Major Business
2.1.3 23andMe, Inc. Personal Genome Testing Product and Solutions
2.1.4 23andMe, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 23andMe, Inc. Recent Developments and Future Plans
2.2 Navigenics
2.2.1 Navigenics Details
2.2.2 Navigenics Major Business
2.2.3 Navigenics Personal Genome Testing Product and Solutions
2.2.4 Navigenics Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Navigenics Recent Developments and Future Plans
2.3 deCODEme
2.3.1 deCODEme Details
2.3.2 deCODEme Major Business
2.3.3 deCODEme Personal Genome Testing Product and Solutions
2.3.4 deCODEme Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 deCODEme Recent Developments and Future Plans
2.4 Color Genomics, Inc.
2.4.1 Color Genomics, Inc. Details
2.4.2 Color Genomics, Inc. Major Business
2.4.3 Color Genomics, Inc. Personal Genome Testing Product and Solutions
2.4.4 Color Genomics, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Color Genomics, Inc. Recent Developments and Future Plans
2.5 Personal Genome Diagnostics, Inc.
2.5.1 Personal Genome Diagnostics, Inc. Details
2.5.2 Personal Genome Diagnostics, Inc. Major Business
2.5.3 Personal Genome Diagnostics, Inc. Personal Genome Testing Product and Solutions
2.5.4 Personal Genome Diagnostics, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
2.6 Counsyl, Inc.
2.6.1 Counsyl, Inc. Details
2.6.2 Counsyl, Inc. Major Business
2.6.3 Counsyl, Inc. Personal Genome Testing Product and Solutions
2.6.4 Counsyl, Inc. Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Counsyl, Inc. Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Personal Genome Testing Product and Solutions
2.7.4 Quest Diagnostics Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
2.8 Gene By Gene, Ltd.
2.8.1 Gene By Gene, Ltd. Details
2.8.2 Gene By Gene, Ltd. Major Business
2.8.3 Gene By Gene, Ltd. Personal Genome Testing Product and Solutions
2.8.4 Gene By Gene, Ltd. Personal Genome Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Gene By Gene, Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Personal Genome Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Personal Genome Testing Players Market Share in 2021
3.2.2 Top 10 Personal Genome Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Personal Genome Testing Players Head Office, Products and Services Provided
3.4 Personal Genome Testing Mergers & Acquisitions
3.5 Personal Genome Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Personal Genome Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Personal Genome Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Personal Genome Testing Revenue Market Share by Application (2017-2022)
5.2 Global Personal Genome Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Personal Genome Testing Revenue by Type (2017-2028)
6.2 North America Personal Genome Testing Revenue by Application (2017-2028)
6.3 North America Personal Genome Testing Market Size by Country
6.3.1 North America Personal Genome Testing Revenue by Country (2017-2028)
6.3.2 United States Personal Genome Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Personal Genome Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Personal Genome Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Personal Genome Testing Revenue by Type (2017-2028)
7.2 Europe Personal Genome Testing Revenue by Application (2017-2028)
7.3 Europe Personal Genome Testing Market Size by Country
7.3.1 Europe Personal Genome Testing Revenue by Country (2017-2028)
7.3.2 Germany Personal Genome Testing Market Size and Forecast (2017-2028)
7.3.3 France Personal Genome Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Personal Genome Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Personal Genome Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Personal Genome Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Personal Genome Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Personal Genome Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Personal Genome Testing Market Size by Region
8.3.1 Asia-Pacific Personal Genome Testing Revenue by Region (2017-2028)
8.3.2 China Personal Genome Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Personal Genome Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Personal Genome Testing Market Size and Forecast (2017-2028)
8.3.5 India Personal Genome Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Personal Genome Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Personal Genome Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Personal Genome Testing Revenue by Type (2017-2028)
9.2 South America Personal Genome Testing Revenue by Application (2017-2028)
9.3 South America Personal Genome Testing Market Size by Country
9.3.1 South America Personal Genome Testing Revenue by Country (2017-2028)
9.3.2 Brazil Personal Genome Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Personal Genome Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Personal Genome Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Personal Genome Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Personal Genome Testing Market Size by Country
10.3.1 Middle East & Africa Personal Genome Testing Revenue by Country (2017-2028)
10.3.2 Turkey Personal Genome Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Personal Genome Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Personal Genome Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Personal Genome Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Personal Genome Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Personal Genome Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Personal Genome Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Personal Genome Testing Revenue Market Share by Region (2023-2028)
Table 6. 23andMe, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. 23andMe, Inc. Major Business
Table 8. 23andMe, Inc. Personal Genome Testing Product and Solutions
Table 9. 23andMe, Inc. Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Navigenics Corporate Information, Head Office, and Major Competitors
Table 11. Navigenics Major Business
Table 12. Navigenics Personal Genome Testing Product and Solutions
Table 13. Navigenics Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. deCODEme Corporate Information, Head Office, and Major Competitors
Table 15. deCODEme Major Business
Table 16. deCODEme Personal Genome Testing Product and Solutions
Table 17. deCODEme Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Color Genomics, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Color Genomics, Inc. Major Business
Table 20. Color Genomics, Inc. Personal Genome Testing Product and Solutions
Table 21. Color Genomics, Inc. Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Personal Genome Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Personal Genome Diagnostics, Inc. Major Business
Table 24. Personal Genome Diagnostics, Inc. Personal Genome Testing Product and Solutions
Table 25. Personal Genome Diagnostics, Inc. Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Counsyl, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Counsyl, Inc. Major Business
Table 28. Counsyl, Inc. Personal Genome Testing Product and Solutions
Table 29. Counsyl, Inc. Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Quest Diagnostics Major Business
Table 32. Quest Diagnostics Personal Genome Testing Product and Solutions
Table 33. Quest Diagnostics Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Gene By Gene, Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Gene By Gene, Ltd. Major Business
Table 36. Gene By Gene, Ltd. Personal Genome Testing Product and Solutions
Table 37. Gene By Gene, Ltd. Personal Genome Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Global Personal Genome Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 39. Global Personal Genome Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 40. Breakdown of Personal Genome Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Personal Genome Testing Players Head Office, Products and Services Provided
Table 42. Personal Genome Testing Mergers & Acquisitions in the Past Five Years
Table 43. Personal Genome Testing New Entrants and Expansion Plans
Table 44. Global Personal Genome Testing Revenue (USD Million) by Type (2017-2022)
Table 45. Global Personal Genome Testing Revenue Share by Type (2017-2022)
Table 46. Global Personal Genome Testing Revenue Forecast by Type (2023-2028)
Table 47. Global Personal Genome Testing Revenue by Application (2017-2022)
Table 48. Global Personal Genome Testing Revenue Forecast by Application (2023-2028)
Table 49. North America Personal Genome Testing Revenue by Type (2017-2022) & (USD Million)
Table 50. North America Personal Genome Testing Revenue by Type (2023-2028) & (USD Million)
Table 51. North America Personal Genome Testing Revenue by Application (2017-2022) & (USD Million)
Table 52. North America Personal Genome Testing Revenue by Application (2023-2028) & (USD Million)
Table 53. North America Personal Genome Testing Revenue by Country (2017-2022) & (USD Million)
Table 54. North America Personal Genome Testing Revenue by Country (2023-2028) & (USD Million)
Table 55. Europe Personal Genome Testing Revenue by Type (2017-2022) & (USD Million)
Table 56. Europe Personal Genome Testing Revenue by Type (2023-2028) & (USD Million)
Table 57. Europe Personal Genome Testing Revenue by Application (2017-2022) & (USD Million)
Table 58. Europe Personal Genome Testing Revenue by Application (2023-2028) & (USD Million)
Table 59. Europe Personal Genome Testing Revenue by Country (2017-2022) & (USD Million)
Table 60. Europe Personal Genome Testing Revenue by Country (2023-2028) & (USD Million)
Table 61. Asia-Pacific Personal Genome Testing Revenue by Type (2017-2022) & (USD Million)
Table 62. Asia-Pacific Personal Genome Testing Revenue by Type (2023-2028) & (USD Million)
Table 63. Asia-Pacific Personal Genome Testing Revenue by Application (2017-2022) & (USD Million)
Table 64. Asia-Pacific Personal Genome Testing Revenue by Application (2023-2028) & (USD Million)
Table 65. Asia-Pacific Personal Genome Testing Revenue by Region (2017-2022) & (USD Million)
Table 66. Asia-Pacific Personal Genome Testing Revenue by Region (2023-2028) & (USD Million)
Table 67. South America Personal Genome Testing Revenue by Type (2017-2022) & (USD Million)
Table 68. South America Personal Genome Testing Revenue by Type (2023-2028) & (USD Million)
Table 69. South America Personal Genome Testing Revenue by Application (2017-2022) & (USD Million)
Table 70. South America Personal Genome Testing Revenue by Application (2023-2028) & (USD Million)
Table 71. South America Personal Genome Testing Revenue by Country (2017-2022) & (USD Million)
Table 72. South America Personal Genome Testing Revenue by Country (2023-2028) & (USD Million)
Table 73. Middle East & Africa Personal Genome Testing Revenue by Type (2017-2022) & (USD Million)
Table 74. Middle East & Africa Personal Genome Testing Revenue by Type (2023-2028) & (USD Million)
Table 75. Middle East & Africa Personal Genome Testing Revenue by Application (2017-2022) & (USD Million)
Table 76. Middle East & Africa Personal Genome Testing Revenue by Application (2023-2028) & (USD Million)
Table 77. Middle East & Africa Personal Genome Testing Revenue by Country (2017-2022) & (USD Million)
Table 78. Middle East & Africa Personal Genome Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Personal Genome Testing Picture
Figure 2. Global Personal Genome Testing Revenue Market Share by Type in 2021
Figure 3. Targeted Testing
Figure 4. Non-Targeted Testing
Figure 5. Multi-Targeted Testing
Figure 6. Personal Genome Testing Revenue Market Share by Application in 2021
Figure 7. Neurological Disorders Picture
Figure 8. Oncology Picture
Figure 9. Metabolic Disorders Picture
Figure 10. Autoimmune Disorders Picture
Figure 11. Others Picture
Figure 12. Global Personal Genome Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Personal Genome Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Personal Genome Testing Revenue Market Share by Region (2017-2028)
Figure 15. Global Personal Genome Testing Revenue Market Share by Region in 2021
Figure 16. North America Personal Genome Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Personal Genome Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Personal Genome Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Personal Genome Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Personal Genome Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Personal Genome Testing Market Drivers
Figure 22. Personal Genome Testing Market Restraints
Figure 23. Personal Genome Testing Market Trends
Figure 24. 23andMe, Inc. Recent Developments and Future Plans
Figure 25. Navigenics Recent Developments and Future Plans
Figure 26. deCODEme Recent Developments and Future Plans
Figure 27. Color Genomics, Inc. Recent Developments and Future Plans
Figure 28. Personal Genome Diagnostics, Inc. Recent Developments and Future Plans
Figure 29. Counsyl, Inc. Recent Developments and Future Plans
Figure 30. Quest Diagnostics Recent Developments and Future Plans
Figure 31. Gene By Gene, Ltd. Recent Developments and Future Plans
Figure 32. Global Personal Genome Testing Revenue Share by Players in 2021
Figure 33. Personal Genome Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Personal Genome Testing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Personal Genome Testing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Personal Genome Testing Revenue Share by Type in 2021
Figure 38. Global Personal Genome Testing Market Share Forecast by Type (2023-2028)
Figure 39. Global Personal Genome Testing Revenue Share by Application in 2021
Figure 40. Global Personal Genome Testing Market Share Forecast by Application (2023-2028)
Figure 41. North America Personal Genome Testing Sales Market Share by Type (2017-2028)
Figure 42. North America Personal Genome Testing Sales Market Share by Application (2017-2028)
Figure 43. North America Personal Genome Testing Revenue Market Share by Country (2017-2028)
Figure 44. United States Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Personal Genome Testing Sales Market Share by Type (2017-2028)
Figure 48. Europe Personal Genome Testing Sales Market Share by Application (2017-2028)
Figure 49. Europe Personal Genome Testing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Personal Genome Testing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Personal Genome Testing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Personal Genome Testing Revenue Market Share by Region (2017-2028)
Figure 58. China Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Personal Genome Testing Sales Market Share by Type (2017-2028)
Figure 65. South America Personal Genome Testing Sales Market Share by Application (2017-2028)
Figure 66. South America Personal Genome Testing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Personal Genome Testing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Personal Genome Testing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Personal Genome Testing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Personal Genome Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
